Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Drug Therapy

Drug Therapy

The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications

Cancer Therapies

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Combined Effects of Drugs: Synergism

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...

Modeling in Therapy

Modeling in Therapy

Modeling, a key technique in therapy, uses observational learning to help clients acquire and practice new skills by watching therapists demonstrate desired behaviors. This approach, rooted in Albert Bandura's concept of vicarious learning, plays a significant role in therapeutic interventions for various psychological conditions, including social anxiety, ADHD, and depression.
Participant Modeling
Participant modeling involves therapists demonstrating calm and effective behaviors in...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Unlocking ferroptosis heterogeneity: ATF4 versus SREBF transcriptional programs.

Cell death discovery·2026

Same author

Overcoming Chemoresistance in Glioblastoma: Mechanisms, Therapeutic Strategies, and Functional Precision Medicine.

International journal of molecular sciences·2026

Same author

Ischaemia/reperfusion and permanent ischaemia differentially affect haemoglobin properties - Possible influence of oxidative stress and adaptation to acute hypoxia.

The FEBS journal·2026

Same author

Neuroinflammatory and Redox Responses in a Rat Model of NTG-Induced Migraine.

International journal of molecular sciences·2026

Same author

In vivo chemogenetic generation of intraneuronal H<sub>2</sub>O<sub>2</sub>.

Free radical biology & medicine·2026

Same author

An Optimized Protocol for Enzymatic Hypothiocyanous Acid Synthesis.

Methods and protocols·2025

Search research articles

Related Experiment Video

Updated: Jan 28, 2026

Diagonal Method to Measure Synergy Among Any Number of Drugs

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

Combination Cancer Therapy and Reference Models for Assessing Drug Synergy in Glioblastoma.

Semyon A Sinyavskiy¹, Nelly S Chmelyuk¹, Daria Yu Travnikova¹

¹Department of Synthetic Neurotechnologies, Pirogov Russian National Research Medical University, Ministry of Health of the Russian Federation, Moscow 117513, Russia.

Current Oncology (Toronto, Ont.)

|January 27, 2026

Summary

Glioblastoma treatment remains challenging due to tumor complexity. This review examines current glioblastoma therapies and models, aiming to improve combination therapy efficacy and clinical translation for malignant gliomas.

Keywords:

anticancer therapy combination index combination therapy drug synergy glioblastoma

More Related Videos

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Published on: October 27, 2014

The Clinical Application of Tumor Treating Fields Therapy in Glioblastoma

The Clinical Application of Tumor Treating Fields Therapy in Glioblastoma

Published on: April 16, 2019

Related Experiment Videos

Last Updated: Jan 28, 2026

Diagonal Method to Measure Synergy Among Any Number of Drugs

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Published on: October 27, 2014

The Clinical Application of Tumor Treating Fields Therapy in Glioblastoma

The Clinical Application of Tumor Treating Fields Therapy in Glioblastoma

Published on: April 16, 2019

Area of Science:

Neuro-oncology
Cancer Therapy
Molecular Biology

Background:

Glioblastoma is an incurable brain cancer with complex treatment challenges.
Current standard treatments include surgery, radiotherapy, and chemotherapy, often in combination.
Therapy efficacy is limited by tumor heterogeneity and intricate molecular pathways.

Purpose of the Study:

To comprehensively review current glioblastoma therapeutic strategies.
To critically evaluate models used for assessing combination therapy efficacy.
To highlight limitations and guide future research for improved clinical management.

Main Methods:

Literature review of glioblastoma treatment modalities.
Analysis of current chemotherapy and immunotherapy combinations.
Evaluation of preclinical and clinical models for therapeutic assessment.

Main Results:

Glioblastoma treatment is multifaceted, involving surgery, radiation, and chemotherapy.
Novel strategies explore chemotherapy combined with immunotherapy.
Tumor heterogeneity and signaling pathways significantly impact treatment outcomes.
Existing models for combination therapy assessment have inherent limitations.

Conclusions:

A deeper mechanistic understanding of glioblastoma therapies is crucial.
Improved models are needed to accurately predict combination therapy effectiveness.
Accelerating the translation of promising in vitro findings to clinical practice is essential for managing malignant gliomas.